251 related articles for article (PubMed ID: 19043921)
41. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
42. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
[TBL] [Abstract][Full Text] [Related]
44. Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene.
Li W; Han M; Li Y; Chen D; Luo X; Ning Q
Biochemistry (Mosc); 2011 Sep; 76(9):1043-50. PubMed ID: 22082274
[TBL] [Abstract][Full Text] [Related]
45. Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.
Billioud G; Pichoud C; Parent R; Zoulim F
J Hepatol; 2012 Jun; 56(6):1269-75. PubMed ID: 22314422
[TBL] [Abstract][Full Text] [Related]
46. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated
Lai MW; Liang KH; Yeh CT
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887289
[TBL] [Abstract][Full Text] [Related]
48. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
[TBL] [Abstract][Full Text] [Related]
49. Dysregulation of the TGFBI gene is involved in the oncogenic activity of the nonsense mutation of hepatitis B virus surface gene sW182*.
Jiang SS; Huang SF; Huang MS; Chen YT; Jhong HJ; Chang IC; Chen YT; Chang JW; Chen WL; Lee WC; Chen MF; Yeh CT; Matsuura I
Biochim Biophys Acta; 2014 Jul; 1842(7):1080-7. PubMed ID: 24662304
[TBL] [Abstract][Full Text] [Related]
50. [Clinical emergence features and implications of hepatitis B virus rtA181T mutation].
Li X; Jiang L; Li F; Liu Y; Dai J; Zhao P; Qin Y; Li J; Xu D
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):23-7. PubMed ID: 25751382
[TBL] [Abstract][Full Text] [Related]
51. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
52. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
53. Characterization of two hepatitis B virus populations in a single Korean hepatocellular carcinoma patient with an HBeAg-negative serostatus: a novel X-Gene-deleted strain with inverted duplication sequences of upstream enhancer site II.
Kim H; Jee Y; Mun HS; Park JH; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Cha CY; Kook YH; Kim BJ
Intervirology; 2007; 50(4):273-80. PubMed ID: 17570929
[TBL] [Abstract][Full Text] [Related]
54. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
55. [Fabrication and property analysis of an oligochips for detecting hepatitis B virus mutant resistant to Lamivudine].
Chen ZB; Gao W; Guan W; Wang SQ
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):46-7. PubMed ID: 12546748
[No Abstract] [Full Text] [Related]
56. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B virus escape mutants induced by antiviral therapy.
Sheldon J; Soriano V
J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
[TBL] [Abstract][Full Text] [Related]
58. The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma.
Gwak GY; Lee DH; Moon TG; Choi MS; Lee JH; Koh KC; Paik SW; Park CK; Joh JW; Yoo BC
Hepatogastroenterology; 2008; 55(88):2028-32. PubMed ID: 19260471
[TBL] [Abstract][Full Text] [Related]
59. [Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
Huang XT; Zeng AP; Lin F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):185-7. PubMed ID: 17653332
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
